This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
A forum of leading hepatologists, endocrinologists and clinical development experts stewarding advances in science, clinical research and therapeutics for nonalcoholic fatty liver disease and steatohepatitis
RECENT EVENTS
5th NASH Roundtable™ Virtual Forum
Thursday June 16, 2022 at 11:30 AM PDT / 02:30 PM EDT
RESOURCES
Fact Sheet: NASH Roundtable™, leading clinical development experts addressing challenges in NASH drug development
View Fact Sheet »MEMBER CO-AUTHORED PUBLICATIONS
June 2022
Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores Read More »
June 2022
Breakthroughs in therapies for NASH and remaining challenges Read More »
May 2022
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool Read More »
May 2022
The Effect of Diabetes and Prediabetes on the Prevalence, Complications and Mortality in Non-alcoholic Fatty Liver Disease Read More »